INGERSOLL-RAND ($IR) posted quarterly earnings results on Thursday, October 30th. The company reported earnings of $0.86 per share, missing estimates of $0.89 by $0.03. The company also reported revenue of $1,955,000,000, missing estimates of $2,008,245,281 by $-53,245,281.
You can see Quiver Quantitative's $IR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INGERSOLL-RAND Insider Trading Activity
INGERSOLL-RAND insiders have traded $IR stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $IR stock by insiders over the last 6 months:
- VICENTE REYNAL (See Remarks) sold 38,657 shares for an estimated $3,209,768
- ANDREW R SCHIESL (See Remarks) sold 11,500 shares for an estimated $976,315
- ELIZABETH MELOY HEPDING (See Remarks) sold 3,500 shares for an estimated $293,230
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
INGERSOLL-RAND Hedge Fund Activity
We have seen 416 institutional investors add shares of INGERSOLL-RAND stock to their portfolio, and 357 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 9,951,597 shares (-55.4%) from their portfolio in Q2 2025, for an estimated $827,773,838
- CAPITAL WORLD INVESTORS added 6,896,970 shares (+34.9%) to their portfolio in Q2 2025, for an estimated $573,689,964
- BLACKROCK, INC. removed 3,739,283 shares (-10.5%) from their portfolio in Q2 2025, for an estimated $311,033,559
- WELLINGTON MANAGEMENT GROUP LLP added 2,132,038 shares (+50.0%) to their portfolio in Q2 2025, for an estimated $177,342,920
- JPMORGAN CHASE & CO removed 1,509,220 shares (-7.6%) from their portfolio in Q2 2025, for an estimated $125,536,919
- JANUS HENDERSON GROUP PLC added 1,492,740 shares (+34.4%) to their portfolio in Q2 2025, for an estimated $124,166,113
- SWEDBANK AB added 1,316,375 shares (+141.1%) to their portfolio in Q3 2025, for an estimated $108,758,902
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INGERSOLL-RAND Congressional Stock Trading
Members of Congress have traded $IR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IR stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 05/21.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 05/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
INGERSOLL-RAND Analyst Ratings
Wall Street analysts have issued reports on $IR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 10/06/2025
- Baird issued a "Outperform" rating on 08/04/2025
- Citigroup issued a "Buy" rating on 07/14/2025
- Barclays issued a "Overweight" rating on 07/09/2025
To track analyst ratings and price targets for INGERSOLL-RAND, check out Quiver Quantitative's $IR forecast page.
INGERSOLL-RAND Price Targets
Multiple analysts have issued price targets for $IR recently. We have seen 6 analysts offer price targets for $IR in the last 6 months, with a median target of $93.0.
Here are some recent targets:
- Nathan Jones from Stifel set a target price of $79.0 on 10/20/2025
- Joseph O'Dea from Wells Fargo set a target price of $95.0 on 10/06/2025
- Chris Snyder from Morgan Stanley set a target price of $85.0 on 08/13/2025
- Michael Halloran from Baird set a target price of $103.0 on 08/04/2025
- Julian Mitchell from Barclays set a target price of $91.0 on 08/04/2025
- Andrew Kaplowitz from Citigroup set a target price of $104.0 on 07/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
